Women in Sleep Congress 2026

May 15, 2026 to May 16, 2026

The Women in Sleep Congress 2026 is a two-day live educational event dedicated to improving the recognition, diagnosis, and management of sleep disorders in female patients. The program explores how sleep disorders present differently in women across key life stages, including adolescence, pregnancy, perimenopause, and post-menopause.

Through expert-led presentations, panel discussions, and real-world case studies, the congress will translate evidence into practical clinical strategies that can be applied immediately in practice.

Target Audience

This activity is designed for an audience of physicians, including Sleep Physicians/Fellows, Neurologists, Sleep Technologists, Physician Associates, Nurse Practitioners and other healthcare professionals.

Learning Objectives

Upon completion of the educational activity, participants should be able to:

Interpret the effects of hormonal transitions across the female lifespan on sleep architecture, circadian rhythm, and disorder presentation to improve clinical recognition and treatment planning.
Evaluate gender-specific considerations in the pharmacologic treatment of sleep disorders, including metabolic, hormonal, and reproductive factors that impact safety and efficacy in female patients.
Apply age- and gender-informed diagnostic strategies to improve identification and early intervention for sleep disorders in adolescent girls and young women.
Develop structured clinical strategies to evaluate and manage sleep disturbances in perimenopausal and menopausal women, with balanced consideration of hormonal and non-hormonal treatment pathways.
Identify and address gender-specific presentation patterns of sleep-disordered breathing in women to improve diagnostic accuracy and treatment uptake.

Criteria for Success
A certificate of completion will be awarded based on the participant's attendance, completion of the online post test and evaluation/claim credit form. akhcme.com/sleep26. Please claim your credit by May 30, 2026. If you have questions about this CE activity, please contact AKH Inc at [email protected].

Commercial Support
This activity is supported from an independent medical education grant from Harmony Biosciences Management, Inc. and Takeda Pharmaceuticals U.S.A., Inc.

CE credit provided by AKH Inc., Advancing Knowledge in Healthcare.

Course summary

Available credit:

11.00 AANP Contact Hours
Nurse Practitioners
This activity has been planned and implemented in accordance with the Accreditation Standards of the American Association of Nurse Practitioners (AANP) through the joint providership of AKH Inc., Advancing Knowledge in Healthcare and . AKH Inc., Advancing Knowledge in Healthcare is accredited by the American Association of Nurse Practitioners as an approved provider of nurse practitioner continuing education. Provider number: 030803. This activity is approved for contact hour(s) (which includes 5.00 hour(s) of pharmacology).
- 5.00 AANP Pharmacology Contact Hours
11.00 AAPA Category 1 CME
AKH Inc., Advancing Knowledge in Healthcare has been authorized by the American Academy of Physician Associates (AAPA) to award AAPA Category 1 CME credit for activities planned in accordance with AAPA CME Criteria. This activity is designated for 11.00 AAPA Category 1 CME credits. PAs should only claim credit commensurate with the extent of their participation.
11.00 AMA PRA Category 1 Credit™ MD/DO
Physicians
AKH Inc., Advancing Knowledge in Healthcare designates this Live Activity for a maximum of 11.00 AMA PRA Category 1 Credit(s)™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
11.00 Attendance
Credits: 11.00

Course opens:

05/15/2026

Course expires:

05/31/2026

Event starts:

05/15/2026 - 10:30am EDT

Event ends:

05/16/2026 - 4:30pm EDT

Cost:

$0.00

Add to calendar:

Rating:

May 15-16, 2026 Course Location: Austin, TX

United States

Disclosures
It is the policy of AKH Inc. to ensure independence, balance, objectivity, scientific rigor, and integrity in all of its continuing education activities. The author must disclose to the participants any significant relationships with ineligible companies whose products or devices may be mentioned in the activity or with the commercial supporter of this continuing education activity. Identified conflicts of interest are mitigated by AKH prior to accreditation of the activity. AKH planners and reviewers have no relevant financial relationships to disclose with ineligible companies whose primary business is producing, marketing, selling, re-selling, or distributing healthcare products used by or on patients.

Disclosure of Unlabeled Use and Investigational Product
This educational activity may include discussion of uses of agents that are investigational and/or unapproved by the FDA. Please refer to the official prescribing information for each product for discussion of approved indications, contraindications, and warnings.

Disclaimer
This course is designed solely to provide the healthcare professional with information to assist in his/her practice and professional development and is not to be considered a diagnostic tool to replace professional advice or treatment. The course serves as a general guide to the healthcare professional, and therefore, cannot be considered as giving legal, nursing, medical, or other professional advice in specific cases. AKH Inc. specifically disclaim responsibility for any adverse consequences resulting directly or indirectly from information in the course, for undetected error, or through participants misunderstanding of the content. If you would like to opt out from future communications from AKH please send an email to [email protected] with your information with "Opt Out" in the subject line.

All of the relevant financial relationships listed for these individuals have been mitigated.

Committee Member, Planner, Staff(s)